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Jaundice in a neonate is one of the most common physical findings, seen in the 1st week of life. Around 60% of term and 80% of preterm neonates develop jaundice in the 1st week of 
life [1]. Jaundice is usually seen due to physiological immaturity 
of neonates, and their inability to handle increased bilirubin 
production during the neonatal period. The pathophysiology of 
jaundice remains the same in both term and pre-term neonates. 
However, there is a higher risk of hyperbilirubinemia in pre-
terms. If not managed, hyperbilirubinemia can lead to bilirubin 
encephalopathy and can cause permanent neurodevelopmental 
handicap [2].
Phototherapy is one of the modalities used in the management 
of hyperbilirubinemia in neonates and is convenient, readily 
available, and easy to use. Long-term experience with 
phototherapy has demonstrated its safety as well as efficacy. 
It converts bilirubin into its water-soluble isomers that can be 
readily excreted without conjugation in the liver. Phototherapy, 
however, also invokes some adverse effects that include loose 
stools, development of rash, overheating, dehydration, damage to 
DNA, retinal injury, hypocalcemia, and a benign condition called 
Bronze Baby Syndrome in cholestasis [3].
Hypocalcemia is one of the known size effects of phototherapy. 
90% of the preterm and 75% of full-term neonates develop 
hypocalcemia in the wake of being subjected to phototherapy [4]. 
Neonates undergo a physiological nadir in serum calcium levels, 
usually by 24–48 h of age, termed early onset hypocalcemia 
and require treatment with calcium supplementation for the first 
72 h. In contrast, late onset hypocalcemia usually presents after 
7 days and requires long-term therapy [5]. The risk of early onset 
hypocalcemia is higher in preterm neonates as well as in other 
high-risk babies.
Serum calcium is present in free physiological form and 
in the bound state. Calcium can be found bound to albumin 
(40%), anions such as phosphate, citrate, sulfate, lactate, and 
phosphate (10%), and free or ionized form (50%). The free form 
is considered to be the most physiologically active form [6]. 
Estimation of total calcium may not reflect actual free calcium 
levels as correlation between the two values may be poor when 
serum albumin concentration is low or in the case of acid-base 
imbalance. Both these conditions may be seen in preterm or sick 
neonates. Hence, measurement of ionized calcium is a far more 
reliable indicator of actual calcium levels of pre-term neonates.
ABSTRACT
Objectives: The objective is to study the occurrence of phototherapy-induced hypocalcemia in neonates with unconjugated 
hyperbilirubinemia and to compare the occurrence between pre-term and full-term neonates. Materials and Methods: The study 
was conducted in the Neonatology Unit of Department of Pediatrics, at a tertiary care teaching hospital for 12 months. A total of 
230 full-term and pre-term neonates with jaundice were recruited. Of 230 neonates, 150 were given phototherapy (cases), while 80 
did not receive phototherapy and were used as control. Serum-ionized calcium levels were measured at initiation, after 24 h and 
after 48 h, or at the end of phototherapy in the case duration of phototherapy was <48 h. Serum-ionized calcium was repeated at 
24 h after the completion of phototherapy. In the control group, ionized calcium levels were measured at the time of development 
of jaundice and 24 h after the initial measurement. Results: Of 150 cases who received phototherapy, 105 were term and 45 were 
preterm. 69 babies (46%) developed hypocalcemia after 24 h of phototherapy. Of these, 28 (40.5%) were preterm and 41 were term 
(59.5%). 4 patients developed symptoms, which included jitteriness and seizures. 62.2% of the total pre-term and 39% of term 
neonates developed hypocalcemia after phototherapy. Conclusion: This study suggests that neonates exposed to phototherapy are 
at the risk of developing hypocalcemia. There is a significant decline in the ionized calcium levels after exposure to phototherapy, 
and this level can even fall to hypocalcemic levels. As the duration of phototherapy increases, the serum levels of calcium may 
decline further. The risk of developing hypocalcemia is higher in pre-term neonates.
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Hypocalcemia can cause serious manifestations such as 
convulsions, apnea, irritability, and jitteriness [7]. Hence, 
phototherapy-induced hypocalcemia can be a significant problem 
in neonates. Most of the studies done previously have observed 
a decline in total serum calcium level in neonates undergoing 
phototherapy. This study was undertaken to determine 
hypocalcemia in neonates with unconjugated hyperbilirubinemia 
that have received phototherapy, by measuring ionized calcium, 
which is a more reliable indicator of clinically significant 
hypocalcemia as well as to compare the occurrence of 
phototherapy-induced hypocalcemia between term and pre-term 
neonates.
MATERIALS AND METHODS
The study was conducted in the Neonatology Unit of Department 
of Pediatrics, at a tertiary care teaching hospital in North India 
for 12 months. Prior approval of the Ethics Committee was 
obtained and a written informed consent was taken from the 
parents. All neonates with unconjugated hyperbilirubinemia, 
both term and preterm, were enrolled in the study. The 
sample size was determined based on Cochran’s estimation 
of sample size. Infants with birth asphyxia (APGAR score <7 
at 5 min), conjugated hyperbilirubinemia, infants requiring 
exchange transfusion, infants receiving intravenous calcium 
supplementation, and infants of diabetic mother were excluded 
from the study.
Neonates with jaundice that required phototherapy were 
included in the case group, and serum-ionized calcium levels 
were measured at initiation of phototherapy, then after 24 h and 
again after 48 h or at the end of phototherapy in case duration 
of phototherapy was <48 h. Serum-ionized calcium was repeated 
at 24 h after completion of phototherapy. In the control group, 
neonates with jaundice not requiring phototherapy were included 
and ionized calcium levels were measured at the time of 
development of jaundice and 24 h after the initial measurement. 
Requirement of phototherapy was decided based on AAP 
Guidelines and according to birth weight in preterm neonates [8]. 
Both light-emitting diode (LED) and compact fluorescent light 
(CFL) units were used for phototherapy. Ionized calcium was 
measured by ion selective electrode method using ST -200 Plus 
Electrolyte Analysis. Serum-ionized calcium level <1.1 mmol/l 
was taken as abnormal.
Data were analyzed using statistical software SPSS 22. The 
comparison of normally distributed continuous variables between 
the groups was performed using Student’s t-test. Nominal 
categorical data between the groups were compared using Chi-
squared test or Fisher’s exact test as appropriate. p<0.05 was 
considered statistically significant.
RESULTS
A total of 230 full-term and pre-term neonates with unconjugated 
hyperbilirubinemia were recruited, of which 150 received 
phototherapy (cases), while 80 did not receive phototherapy and 
were used as control. The total number of males in the study was 
139 and females was 91, with a male:female ratio of 1.5:1. There 
was no statistically significant difference between the two groups 
based on sex of the newborns. Of a total of 230 neonates, 178 
were born full-term (77.4 %) and 52 were pre-term (22.6 %). Of 
150 cases, 105 (70 %) were term deliveries and 45 (30%) were 
preterm. Of 80 controls, there were 73 term newborns (91.3 %) 
and 7 pre-terms (8.8%). The difference between the two was 
statistically significant. The mean birth weight of cases was 
2596.93±561.37 g and controls was 2900.34±465.51 g (p<0.001).
The serum total bilirubin levels were measured in 230 
newborns with jaundice at the time of detection of icterus. The 
mean bilirubin levels at the time of starting phototherapy among 
150 cases were 14.53±3.17 mg/dl, while in the control group, it 
were 10.59±2.12 (p<0.001) as shown in Table 1. Ionized calcium 
levels were measured in all neonates included in the study. The 
mean ionized calcium at the time of detection of jaundice in the 
case group was 1.26±0.14 and in the control group was 1.26±0.15, 
which was comparable.
The mean ionized calcium after 24 h of phototherapy in case 
group was 1.13±0.20. In the control group, ionized calcium 
was repeated after 24 h of initial measurement and mean level 
was 1.28±0.11 (p<0.001). In the case group, serial decline in 
ionized calcium levels was noted as the duration of phototherapy 
increased, and this decline was statistically significant (Table 2). 
Mean ionized calcium levels at 24 h after stopping phototherapy 
(post PT) were 1.23±0.10. In the neonates where calcium levels 
did not return to normal despite stopping phototherapy, repeat 
levels were measured on day 7 and showed a mean value of 
1.20±0.06.
Table 1: Comparison of baseline characteristics between cases and 
controls (total n=230)
Baseline 
characteristics
Cases, n (%) Control, n (%) P 
Sex distribution
Male 96 (64) 43 (53.8) 0.130
Female 54 (36) 37 (46.3)
Mode of delivery
NVD 68 (45.3) 27 (33.8) 0.089
LSCS 82 (54.7) 53 (66.3)
Birth weight (g) 
(mean)
2596.93±561.37 2900.34±465.51 <0.001
Total bilirubin at 
admission  
(mg/dl) (mean)
14.53±3.17 10.59±2.12 <0.001
AGA 124 73
SGA 26
Birth weight 
category
Normal 88 (58.7) 67(83.8)
LBW 57 (38) 13 (16.3)
VLBW 5 (3.3) 0 (0)
NVD: Normal vaginal delivery, LSCS: Lower segment cesarean section, SGA: Small for 
gestational age, AGA: Average for gestational age, LBW: Low birth weight, VLBW: Very 
low birth weight
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Of 230 patients included in the study, the number of patients 
developing hypocalcemia (ionized calcium value <1.1 mmol/L) 
after 24 h of initial testing was 73 (31.7%), which included both 
cases and controls. Of 150 cases, 69 developed hypocalcemia 
after 24 h of phototherapy (46%). Of 80 controls, only 4 patients 
developed hypocalcemia (5%). The difference between the two 
groups was statistically significant (p<0.001), (Table 3).
Of a total of 150 cases, there were 45 preterm and 105 term 
patients. Of 45 preterm neonates who received phototherapy, 
62.2% developed hypocalcemia (28 cases) and 39% term neonates, 
of 105 (41 cases) who received phototherapy showed a decline 
in ionized calcium to hypocalcemic levels. This difference was 
statistically significant (p=0.009). 4 neonates (2.7%) of 150 cases 
developed symptoms that included jitteriness and seizures. 97.3% 
neonates were asymptomatic. None of the patients in the control 
group showed any symptoms. The most common symptom was 
jitteriness.
DISCUSSION
Neonatal hyperbilirubinemia is one of the most common 
morbidities in neonates and a common cause of readmission 
to hospitals. It occurs in both term and preterm neonates. The 
growing practice of early discharge of newborns has resulted in 
a re-emergence of bilirubin-related neurological sequelae, and 
hence, there is a growing use of interventions for the management 
of hyperbilirubinemia in newborns. With an increase in the use 
of phototherapy, there is also concern about an increase in the 
development of side effects in the babies exposed to these special 
blue lamps.
Our aim was to estimate the occurrence of hypocalcemia 
induced by phototherapy and to compare the occurrence 
between terms and pre-terms. Currently, there are no established 
protocols for the routine supplementation of calcium to neonates 
receiving phototherapy. We aimed at studying the occurrence of 
phototherapy-induced hypocalcemia as well as the occurrence of 
possible symptoms due to hypocalcemia.
Ionized calcium is the active form of calcium in the body. 
Estimation of total calcium at times may not reliably give 
a measure of the active serum calcium levels. In our study, 
estimation of ionized calcium was done to allow for a reliable 
correlation of serum value and careful observation could be done 
for neonates developing hypocalcemia for early detection of any 
possible symptoms. In our study, 150 newborns were taken as 
cases and 80 neonates were included in the control group. In the 
case group, ionized calcium levels were measured at 24 h after 
the neonate underwent phototherapy. 69 of 150 cases developed 
hypocalcemia (46%), which was comparable to that found in a 
study by Durga and Kumar [9].
Serial measurement of ionized calcium levels was done in our 
study after starting phototherapy. There was a significant decline 
in the level of calcium as the duration of phototherapy increased, 
measured at 24 h and 48 h after starting phototherapy, which was 
also recorded by Srinivasa et al. [10]. Eghbalian and Monsef also 
found a decline in calcium levels as the duration of phototherapy 
increased [11].
Ionized calcium values measured at 48 h after starting 
phototherapy showed a significant decline as compared with 
values at 24 h. In studies by Alizadeh-Taheri et al., 56% of the 
neonates showed a decline in calcium levels. However, in their 
study, development of hypocalcemia was documented only in 
7% of neonates, measured 48 h after phototherapy. Although 
the absolute number of patients developing hypocalcemia was 
low, there was a statistically significant decline in the calcium 
levels after 48 h of phototherapy, which was comparable in our 
study [12].
Follow-up ionized calcium levels were done in all neonates 
who received phototherapy 24 h after stopping phototherapy in 
our study. Out of the 69 patients that developed hypocalcemia, 
calcium values returned to normal after 24 h of stopping 
phototherapy in all but 4 patients (5.7 %). Karamifar et al. 
found in their study that in all cases of hypocalcemia, serum 
calcium levels came back to normal after 24 h of stopping 
phototherapy [13]. Xiong et al. also noted that in almost all 
cases, levels of calcium returned to normal 24 h after stopping 
phototherapy [14], whereas, in a study by Yadav et al., serum 
calcium levels returned to normal values by 10 days of life [15]. 
In our study, serum calcium was repeated on day 7 after 
phototherapy for the 5.7% of patients in whom calcium values 
did not return to normal at 24 h after stopping phototherapy. It 
was found that in all cases, calcium values attained normal level 
as confirmed in above study [15].
Comparison was made between the number of term babies 
developing hypocalcemia against the number of pre-terms after 
receiving phototherapy. Hence, in our study, 62.2% of pre-terms and 
Table 2: Mean ionized calcium levels in study population (n=230)
Ionized calcium 
levels (mmol/L) 
mean±SD
Cases Control P
0 h 1.26±0.14 1.26±0.15 0.868
24 h 1.13±0.20 1.28±0.11 <0.001
48 h 1.079±0.21 − −
Post PT 1.23±0.10 − −
Day 7 1.2±0.06 − −
SD: Standard deviation
Table 3: Neonates developing hypocalcemia in the study 
population (n=230)
I.Ca Frequency (%) P
Cases Control
0 h
Normal 139 (92.7) 76 (95.0) 0.585
Abnormal 11 (7.3) 4 (5.0)
Total 150 (100) 80 (100)
24 h
Normal 81 (54.0) 76 (95.0) <0.001
Abnormal 69 (46.0) 4 (5.0)
Total 150 (100) 80 (100)
Pal et al.  Effect of phototherapy on serum-ionized calcium
Vol 5 | Issue 4 | Apr 2018 Indian J Child Health 287
39% of term neonates developed hypocalcemia after phototherapy, 
and this difference was statistically significant. Sethi et al. also 
found a higher prevalence of hypocalcemia after phototherapy in 
pre-term neonates as compared to term neonates [4]. Jain et al. 
noted phototherapy-induced hypocalcemia in 55% of pre-terms 
and 30% of full-term neonates, which was in comparison to 
our results [16]. Various studies concluded that phototherapy-
induced hypocalcemia can be a cause of serious concern in pre-
terms, in whom the risk of physiological hypocalcemia is higher 
as compared to term neonates [17]. Further studies need to be 
undertaken before the development of policies that advise for 
prophylactic intervention in neonates on phototherapy.
Although many studies have documented a significant decline 
in levels of calcium after phototherapy, as was also seen in our 
study, some studies show a lower prevalence of hypocalcemia. 
Gheshmi et al. found that while 54% of patients had decreased 
calcium levels after phototherapy, only 9% of patients developed 
hypocalcemia. They concluded that the risk of hypocalcemia was 
low in healthy term neonates and did not recommend the use of 
prophylactic calcium in these neonates [18].
In contrast, a study by Prabhakar et al. where ionic calcium 
levels were measured instead of total calcium observed a 
significant decline in serum ionic calcium level  in the study 
group as compared to control. They also noted the development 
of symptoms including jitteriness, lethargy, and irritability. 
However, in their study, none of the neonates developed seizures. 
They advised for the supplementation of calcium prophylactically 
in neonates who are at high risk of developing symptomatic 
hypocalcemia [19].
The underlying mechanism for phototherapy-induced 
hypocalcemia is although not yet well understood, but it seems 
that hypocalcemia is accompanied by a decrease in serum 
melatonin concentration. Melatonin secretion is regulated by 
the pineal gland, which is shown to be influenced by the diurnal 
variation. Melatonin increases the release of cortisol, which plays 
an important role in calcium homeostasis by decreasing calcium 
absorption by bones, hence maintaining serum calcium levels. 
Phototherapy prompts restraint of pineal gland by transcranial 
brightening and inhibits pineal secretion of melatonin bringing 
about a decrease in melatonin levels. Subsequently, hypocalcemia 
develops due to decrease in cortisol levels as the uptake of calcium 
by bones is increased [20].
Kargar et al. studied the effect of covering the neonate’s heads 
with hats/caps while providing phototherapy. The neonates in 
the case group received phototherapy while wearing a hat, and 
the control group received phototherapy without hats. Calcium 
levels were tested in both groups at baseline and 24 as well 
as 48 h after phototherapy. 38.8% of newborns in the control 
group and 13.8% in the case group had hypocalcemia after 
phototherapy. A significant difference was found between the 
incidence of hypocalcemia in these two groups (p=0.03). Hence, 
they concluded that phototherapy-induced hypocalcemia can be 
prevented by the head cap during phototherapy with no need for 
prophylactic administration of calcium [21].
Limitations of this study include the use of both CFL and 
LED phototherapy and no correlation between the level of 
hypocalcemia and type of phototherapy used as well as unequal 
number of term and preterm neonates enrolled in both study 
and control groups. Age at the onset of jaundice and starting 
phototherapy was not correlated with the onset of hypocalcemia. 
Physiological hypocalcemia noted during the first 72 h of life may 
be a cause for further decline in serum calcium levels and may 
affect the results and be indistinguishable from phototherapy-
induced hypocalcemia.
CONCLUSION
This study showed that neonates on phototherapy are at risk 
of developing hypocalcemia and hence should be monitored 
with serial serum calcium measurement for timely detection of 
hypocalcemia before the occurrence of symptoms.
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